共 42 条
[1]
Castro J(2014)Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome Proc Natl Acad Sci USA 111 9941-9946
[2]
Garcia RI(2014)Synaptic, transcriptional and chromatin genes disrupted in autism Nature 515 209-215
[3]
Kwok S(2015)NNZ-2566, a novel analog of (1-3) IGF-1, as a potential therapeutic agent for fragile X syndrome Neuromolecular Med 17 71-82
[4]
Banerjee A(2014)The contribution of de novo coding mutations to autism spectrum disorder Nature 515 216-221
[5]
Petravicz J(2014)The challenges of clinical trials in fragile X syndrome Psychopharmacology 231 1237-1250
[6]
Woodson J(2014)Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome Proc Natl Acad Sci USA 111 4596-4601
[7]
De Rubeis S(2014)A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome Dis Model Mech 7 1047-1055
[8]
He X(undefined)undefined undefined undefined undefined-undefined
[9]
Goldberg AP(undefined)undefined undefined undefined undefined-undefined
[10]
Poultney CS(undefined)undefined undefined undefined undefined-undefined